LifeArc and Metrion Biosciences extend partnership agreement to support LifeArc's neuroscience small molecule drug discovery programme. Metrion to provide assay support for medicinal chemistry, plus translational and CiPA-compliant safety assays. See press release here.
Metrion Biosciences will be attending the forthcoming Safety Pharmacology Society meeting in Berlin, 24-27 September 2017. Jim Beaumont and John Ridley will be on booth #216, contact them here if you would like to schedule an appointment. Metrion will also be presenting four posters: "Comprehensive Profiling of Axiogenesis Ventricular vCor.4U iPSC-Derived Cardiomyocytes – From Electrophysiology to [...]
Q2 2017 was another productive quarter for the Metrion Biosciences team. Our stand-alone CRO sales continued on an upward trajectory, with both April and June revenues beating our previous best months for invoiced sales and total H1 2017 stand-alone CRO revenue being well above our 2016 figure. Our FTE-based collaborations also performed well, delivering high quality [...]
Invitation extended to external scientists to attend TRP channel focused presentation by leading UK academic. The fourth presentation in Metrion Biosciences external speaker series will be given by Professor Stuart Bevan (King's College London) and will be entitled "The roles of TRPA1 and TRPM3 ion channels in pain and nociception". The presentation will take place [...]
Metrion Biosciences is pleased to announce it will be attending the forthcoming 2017 BIO International Convention in San Diego, CA ( 19th - 22nd June). Metrion will be represented by its new Head of Business Development, Jim Beaumont, who will be pleased to meet with clients both old and new who are attending the biotech industry’s largest annual [...]
Metrion appoints Chief Operating Officer and Head of Business Development. The full press release can be found here.
Metrion announce collaboration to search for novel modulators of ion channels with proven therapeutic potential. The full press release can be found here.
Metrion's collaboration with Assay.Works featured in the April 2017 edition of Drug Discovery News. The article can be found here.